Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Ammodo KNAW Award voor Jeroen Geurts
jan 2017 | Multipele Sclerose